| Mas M, Farre M, de la Tor... |
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... |
J Pharmacol Exp Ther |
1999 |
| Ortuno J, Pizarro N, Farr... |
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites... |
J Chromatogr B Biome... |
1999 |
| de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| Cami J, Farre M, et al |
Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... |
J Clin Psychopharmac... |
2000 |
| de la Torre R, Farre M, R... |
Pharmacology of MDMA in humans |
Ann N Y Acad Sci |
2000 |
| Pacifici R, Zuccaro P, Fa... |
Immunomodulating activity of MDMA |
Ann N Y Acad Sci |
2000 |
| Farré M, Roset PN, de la ... |
Interaction of Paroxetine and MDMA in humans |
College on Problems... |
2002 |
| Hernandez-Lopez C, Farre ... |
3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions i... |
J Pharmacol Exp Ther |
2002 |
| Pizarro N, Ortuno J, Farr... |
Determination of MDMA and its metabolites in blood and urine by gas ch... |
J Anal Toxicol |
2002 |
| de la Torre R, Farre M, R... |
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... |
Ther Drug Monit |
2004 |
| de la Torre R, Farre M, O... |
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in ni... |
Eur J Clin Pharmacol |
2005 |
